Skip to main content

Table 2 Logistic regression analysis of glucose-related variables between plaque rupture and erosion

From: The association between glucose-related variables and plaque morphology in patients with ST-segment elevated myocardial infarction

Exposure Statistics Non-adjusted Adjustment I Adjustment II
HbA1c (%) 6.43 ± 1.44 1.19 (1.03, 1.36) 0.0153 1.13 (0.98, 1.30) 0.0915 1.12 (0.97, 1.30) 0.1264
ARPG (mmol/L) 9.30 ± 3.80 1.08 (1.03, 1.13) 0.0018 1.06 (1.01, 1.12) 0.0141 1.06 (1.01, 1.11) 0.0256
PFPG (mmol/L) 7.95 ± 3.56 1.03 (0.98, 1.08) 0.2441 1.01 (0.96, 1.06) 0.7984 1.01 (0.96, 1.06) 0.8090
A/C 1.25 ± 0.37 1.60 (0.94, 2.73) 0.0858 1.46 (0.85, 2.51) 0.1714 1.43 (0.83, 2.45) 0.1943
DM history
 No 634 (72.7%) 1 1 1
 Yes 238 (27.3%) 1.53 (1.06, 2.21) 0.0231 1.42 (0.96, 2.09) 0.0800 1.38 (0.92, 2.05) 0.1155
GVT
 Normal 49 (6.4%) 1 1 1
 Up 210 (27.5%) 2.83 (1.48, 5.39) 0.002 2.01 (1.02, 3.99) 0.045 2.03 (1.02, 4.07) 0.044
 Down 504 (66.1%) 2.83 (1.56, 5.14) 0.001 2.16 (1.15, 4.04) 0.016 2.04 (1.09, 3.85) 0.027
Strati-HbA1c
 < 6.5 471 (70.2%) 1 1 1
 ≥ 6.5 200 (29.8%) 1.18 (0.45, 3.12) 0.7393 1.29 (0.47, 3.54) 0.6234 1.34 (0.48, 3.76) 0.5778
Strati-ARPG
 < 6.1 117 (13.4%) 1 1 1
 ≥ 6.1, < 7.1 144 (16.5%) 1.41 (0.84, 2.37) 0.1909 1.25 (0.71, 2.20) 0.4396 1.17 (0.66, 2.08) 0.5945
 ≥ 7.1, < 11.1 412 (47.3%) 2.07 (1.32, 3.24) 0.0014 1.63 (1.00, 2.67) 0.0517 1.58 (0.96, 2.61) 0.0736
 ≥ 11.1 199 (22.8%) 2.29 (1.24, 4.21) 0.0080 2.05 (1.05, 3.99) 0.0345 1.99 (1.02, 3.90) 0.0438
Strati-PFPG
 < 5.6 204 (26.7%) 1 1 1
 ≥ 5.6, < 6.1 88 (11.5%) 0.92 (0.53, 1.60) 0.7804 0.81 (0.46, 1.44) 0.4826 0.87 (0.49, 1.56) 0.6417
 ≥ 6.1, < 7.0 112 (14.7%) 1.01 (0.61, 1.70) 0.9603 0.90 (0.52, 1.53) 0.6905 0.90 (0.52, 1.55) 0.7027
 ≥ 7.0 359 (47.1%) 1.37 (0.93, 2.04) 0.1145 1.10 (0.72, 1.67) 0.6527 1.14 (0.74, 1.74) 0.5611
  1. Data are presented as OR (95% CI) P value. Adjustment I for: age; gender; HTN history; current smoking; LDL-C. Adjustment II for: age; gender; HTN history; current smoking; LDL-C; initial TIMI flow; multivessel lesion, and culprit vessel
  2. A/C admission/chronic glycaemia ratio, ARPG admission random plasma glucose, DM diabetes mellitus, GVT glucose variable tendency, HbA1c glycosylated hemoglobin, HTN hypertension, LDL-C low density lipoprotein cholesterol, PCI percutaneous coronary intervention, PFPG post-PCI fasting plasma glucose, Strati- stratification, TIMI thrombolysis in myocardial infarction